E 5156 (PAPAVERINE 150 MG)
Pill imprint E 5156 has been identified as Papaverine hydrochloride 150 MG.
Papaverine is used in the treatment of vasospasm and belongs to the drug class peripheral vasodilators. FDA has not classified the drug for risk during pregnancy. Papaverine 150 MG is not subject to the Controlled Substances Act.
See also related documents.
More about papaverine
- Papaverine capsules
- Papaverine injection
- Papaverine (Advanced Reading)
- Papaverine Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.